Kehl, Germany

Frank Bolkenius

This inventor holds 7 USPTO granted patents and 1 published patent application, plus 5 CIPO patents and 2 EPO patents. Top assignees: Merrell Pharmaceuticals, Inc., Sanofi-Synthelabo, Hoechst Marion Roussel. Active years: 1996-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frank Bolkenius. Retrieved from https://idiyas.com/inventor/frank-bolkenius

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7 

% Patents Active = 85.7

 

 

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 1996-2005

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Frank Bolkenius

Introduction

Frank Bolkenius is a notable inventor based in Kehl, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his work on benzimidazole derivatives. With a total of seven patents to his name, Bolkenius has established himself as a key figure in the development of therapeutic applications.

Latest Patents

Among his latest patents is a groundbreaking invention related to benzimidazole derivatives, which includes a preparation process and therapeutic applications. This invention focuses on the general formula (I) of these derivatives, showcasing their potential in medical treatments. His work in this area highlights the importance of innovative solutions in addressing health challenges.

Career Highlights

Throughout his career, Frank Bolkenius has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Merrell Pharmaceuticals, Inc. and Sanofi-Synthelabo. His experience in these organizations has contributed to his expertise and success as an inventor.

Collaborations

Frank Bolkenius has collaborated with esteemed colleagues, including J Martin Grisar and Margaret A Petty. These partnerships have likely enriched his research and development efforts, leading to impactful innovations in the pharmaceutical sector.

Conclusion

Frank Bolkenius is a distinguished inventor whose work on benzimidazole derivatives has the potential to transform therapeutic practices. His contributions to the pharmaceutical industry reflect a commitment to innovation and excellence.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…